Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.48 |
| ▸ | CD22 | P20273 | 17/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17854010 | 0.87 | SIGLEC7 (0.51) | SIGLEC7CD22 | |
| SCHEMBL17897329 | 0.84 | SIGLEC7 (0.53) | SIGLEC7CD22 | |
| SCHEMBL17988604 | 0.81 | SIGLEC7 (0.56) | SIGLEC7CD22 | |
| SCHEMBL17853997 | 0.80 | CD22 (0.41) | SIGLEC7CD22 | |
| SCHEMBL17854014 | 0.79 | SIGLEC7 (0.63) | SIGLEC7CD22 | |
| SCHEMBL15473997 | 0.79 | SIGLEC7 (0.59) | SIGLEC7CD22 | |
| SCHEMBL18733276 | 0.78 | CD22 (0.43) | SIGLEC7CD22 | |
| SCHEMBL31668635 | 0.78 | CD22 (0.43) | SIGLEC7CD22 | |
| SCHEMBL18732828 | 0.78 | CD22 (0.43) | SIGLEC7CD22 | |
| SCHEMBL20193260 | 0.78 | SIGLEC7 (0.47) | SIGLEC7CD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160175421-A1 | GLYCAN CONJUGATES AND USE THEREOF | WONG CHI-HUEY (US) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160175421-A1 | GLYCAN CONJUGATES AND USE THEREOF | FUT5, GNE, B3GNT2 | SIGLEC7 7/4885CD22 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.